WISE WQLF SAYS: It is now clear and CONFIRMS what the WQLF acknowledged in his premise the reasoning behind the increase of the Authorized Common and Preferred Shares and the subsequent Reverse split option, if needed in the future. The bashers and naysayers after the probable M&A announcement of a private European company merging with CV Sciences has now changed their fear mongering narrative to BS rhetoric YQU Understand. It is apparent that the merger will be a stock swap with no monies involved in the transaction. How many CVSI shares will it take for the merger to be approved and completed? The outstanding according to the WQKE company known as Yahoo has outstanding shares at 154.6 Million. If the stock swap is close to 154 million shares of CVSI stock, even though it is undervalued, the market cap with an increase to 300 million shares at the current price of $.03 makes it a 9 Million dollar concern. If undervaluation is not considered, the stock price of CVSI stock could settle around 2 cents a share bringing the market capitalization to around $6 Million. The market cap before the announcement was between 6 to 7.5 Million. If the merger of the two companies does take place, the pros for CVSI will be the easiest entrance into the CBD European market. It also gives the private European entity an easier access to the USA market for their products as well. This merger has been contemplated for a few years and it is now being implemented. In his outline of the merger, JD the DJ stated that it was a non binding letter of intent and could easily be agreed to upon shareholder approval. This is the merger we longs have been patiently waiting for in terms of the survival of the fittest in the CBD sector. Congratulations to the longs and to the basher with numerous aliases, good luck with your Woke narratives. They simply do not alter the fact that the best public company to invest in the CBD sector is CV Sciences. The data that one is considered misinformation comes from your Woke brethren’s Yahoo. Have Mercy Have PARTNERS Have Patience Have Faith WISE WQLF Ahooooooo
JD Said;
JD THE DJ SAID;
“ We are transitioning to become a global health and wellness company that will not only participate in the CBD category, but also leverage our strengths to pursue non-CBD nutraceuticals and other plant-based food products. Over the last several quarters, we have discussed our participation in select M&A opportunities. As part of this process, we have evaluated numerous opportunities that would allow us to leverage our strength and assets that I just described. We are being extremely selective, making sure that anything we do must be a good strategic fit with favorable economics to our shareholders.”
“ With that context, I am pleased to announce that we have executed a nonbinding letter of intent to acquire a plant-based food company in Europe. Closing of this important strategic acquisition is expected to occur before the end of the year. The challenges in our industry continue, but we are well positioned with an efficient business model and operating structure. We continue to streamline operation, increase cost efficiency and are positioned to leverage our company’s assets and strengths, both organically and through our M&A strategy. We are moving towards profitability and cash flow positive in the near term because of tough decisions that we have made over the last several years. Let me pause now, and I will turn the call over to Joerg.”
CVSI Data from WOKE Yahoooooo
Valuation Measures4
Market Cap (intraday) 4.64M
Enterprise Value 3.21M
Trailing P/E 3.00
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 0.28
Price/Book (mrq) 1.33
Enterprise Value/Revenue 0.20
Enterprise Value/EBITDA 1.36
Trading Information
Stock Price History
Beta (5Y Monthly) N/A
52-Week Change 3 0.00%
S&P500 52-Week Change 3 14.28%
52 Week High 3 0.0600
52 Week Low 3 0.0290
50-Day Moving Average 3 0.0414
200-Day Moving Average 3 0.0432
Share Statistics
Avg Vol (3 month) 3 309.71k
Avg Vol (10 day) 3 478.73k
Shares Outstanding 5 154.6M
Implied Shares Outstanding 6 154.6M
Float 8 152.07M
% Held by Insiders 1 0.02%
% Held by Institutions 1 0.00%
Shares Short 4 N/A
Short Ratio 4 N/A
Short % of Float 4 N/A
Short % of Shares Outstanding 4 N/A
Shares Short (prior month ) 4 N/A
Dividends & Splits
Forward Annual Dividend Rate 4 N/A
Forward Annual Dividend Yield 4 N/A
Trailing Annual Dividend Rate 3 0.00
Trailing Annual Dividend Yield 3 0.00%
5 Year Average Dividend Yield 4 N/A
Payout Ratio 4 0.00%
Dividend Date 3 N/A
Ex-Dividend Date 4 N/A
Last Split Factor 2 N/A
Last Split Date 3 N/A
Financial Highlights
Fiscal Year
Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq) Sep 29, 2023
Profitability
Profit Margin 4.59%
Operating Margin (ttm) -10.69%
Management Effectiveness
Return on Assets (ttm) 16.91%
Return on Equity (ttm) 30.47%
Income Statement
Revenue (ttm) 16.07M
Revenue Per Share (ttm) 0.10
Quarterly Revenue Growth (yoy) 9.00%
Gross Profit (ttm) N/A
EBITDA 3.6M
Net Income Avi to Common (ttm) 738k
Diluted EPS (ttm) 0.0100
Quarterly Earnings Growth (yoy) N/A
Balance Sheet
Total Cash (mrq) 1.64M
Total Cash Per Share (mrq) 0.01
Total Debt (mrq) 219k
Total Debt/Equity (mrq) 6.30%
Current Ratio (mrq) 1.39
Book Value Per Share (mrq) 0.02
Cash Flow Statement
Operating Cash Flow (ttm) 2.58M
Levered Free Cash Flow (ttm) 989.62
Bullish
